Adar1-Capital-Management

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
198
Total Value
523731625
Accession Number
0001940272-25-000003
Form Type
13F-HR
Manager Name
Adar1-Capital-Management
Data Enrichment
82% identified
163 identified35 unidentified

Holdings

198 positions
Manager:
Search and click to pin securities to the top
Page 3 of 10
BioAge Labs, Inc.
Shares:971.1K
Value:$3.7M
Zura Bio Ltd
Shares:2.8M
Value:$3.6M
SOLENO THERAPEUTICS INC
Shares:50.0K
Value:$3.6M
Astria Therapeutics, Inc.
Shares:641.7K
Value:$3.4M
Rezolute, Inc.
Shares:1.1M
Value:$3.2M
Centessa Pharmaceuticals plc
Shares:216.2K
Value:$3.1M
Akero Therapeutics, Inc.
Shares:71.1K
Value:$2.9M
Merus N.V.
Shares:67.0K
Value:$2.8M
10806XAH5
Shares:
Value:$2.7M
PTC THERAPEUTICS, INC.
Shares:50.0K
Value:$2.5M
REGENXBIO Inc.
Shares:350.4K
Value:$2.5M
ARDELYX, INC.
Shares:490.7K
Value:$2.4M
10806XAB8
Shares:
Value:$2.3M
DYNAVAX TECHNOLOGIES CORP
Shares:170.0K
Value:$2.2M
ARVINAS, INC.
Shares:313.4K
Value:$2.2M
G0544A103
Shares:215.0K
Value:$2.2M
RHYTHM PHARMACEUTICALS, INC.
Shares:36.9K
Value:$2.0M
Summit Therapeutics Inc.
Shares:100.0K
Value:$1.9M
DELCATH SYSTEMS, INC.
Shares:149.4K
Value:$1.9M
Crinetics Pharmaceuticals, Inc.
Shares:53.1K
Value:$1.8M